Latest Breaking News On - Gain therapeutics inc - Page 7 : comparemela.com

Gain Therapeutics GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson s Disease -February 06, 2024 at 08:03 am EST

Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level of control armBETHESDA, Md., Feb. 06, 2024 .

San diegoUnited statesNic johnsonElio ambrosioMatthias alderDrug administrationGain therapeutics incExchange commission onExchange commissionMichaelj fox foundation for parkinson researchSilverstein foundation for parkinsonCompany annual report on formGain therapeutic chief executiveNeurofilament light chainSilverstein foundationGain therapeutics

UPDATE - Gain Therapeutics GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson s Disease

UPDATE - Gain Therapeutics GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesElio ambrosioMatthias alderDrug administrationExchange commissionCompany annual report on formGain therapeutics incMichaelj fox foundation for parkinson researchSilverstein foundation for parkinsonExchange commission onGain therapeutic chief executiveNeurofilament light chainSilverstein foundationGain therapeuticsSite directed enzyme enhancement therapy

UPDATE - Gain Therapeutics GT-02287 Completely Restores

Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level.

San diegoUnited statesElio ambrosioNic johnsonMatthias alderGain therapeutics incExchange commission onSilverstein foundation for parkinsonMichaelj fox foundation for parkinson researchExchange commissionDrug administrationCompany annual report on formGain therapeutic chief executiveNeurofilament light chainSilverstein foundationGain therapeutics

Gain Therapeutics GT-02287 Completely Restores Motor Function In Mouse Models Of Parkinson S Disease

Gain Therapeutics GT-02287 Completely Restores Motor Function In Mouse Models Of Parkinson S Disease
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMatthias alderNic johnsonElio ambrosioExchange commissionCompany annual report on formMichaelj fox foundation for parkinson researchExchange commission onSilverstein foundation for parkinsonDrug administrationGain therapeutics incGain therapeutic chief executive officerNeurofilament light chainSilverstein foundationGain therapeutics

Gain Therapeutics CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update -January 31, 2024 at 08:01 am EST

BETHESDA, Md., Jan. 31, 2024 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today releases the following letter.

Comunidad autonoma de catalunaSan diegoUnited statesXavi barrilElena cuberoMatthias alderMovement disordersGain therapeutics incStage biotech companyInternational conference on alzheimerExchange commissionInternational congressOrganizational developmentUniversity of barcelonaInstitute for researchBusiness development